Literature DB >> 10908694

Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.

T Tomita1, H Takano, N Tomita, R Morishita, M Kaneko, K Shi, K Takahi, T Nakase, Y Kaneda, H Yoshikawa, T Ochi.   

Abstract

OBJECTIVE: Numerous cytokines are expressed in lesions of synovial hyperplasia of patients with rheumatoid arthritis (RA), and their pathophysiological contributions have been the subject of speculation. These genes are regulated by the transcription factor NFkappaB which in turn is activated by tumour necrosis factor-alpha (TNF-alpha) and cytokines. In this study we examined the inhibition of the production of pro-inflammatory cytokines, adhesion molecule and matrix metalloproteinase (MMP) from synovial tissue of patients with RA by the introduction of synthetic double-stranded DNA with high affinity for the NFkappaB binding site.
METHOD: NFkappaB decoy oligonucleotides (ODN) were introduced with the aid of the haemagglutinating virus of Japan (HVJ)-liposome method into synovial tissue or synovial cells derived from patients with RA. The levels of interleukin-1beta (IL-1beta), IL-6, TNF-alpha, intercellular adhesion molecule-1 (ICAM-1) and MMP-1 were determined by means of enzyme-linked immunosorbent assay (ELISA) and Northern blotting analysis. A cell counting kit was used to study the effect of NFkappaB decoy ODN on synovial cell proliferation.
RESULTS: The production of these mediators was significantly inhibited by the introduction of NFkappaB decoy ODN compared with the effect of scrambled decoy ODN. Transfection of NFkappaB decoy ODN resulted in a significant inhibition of synovial cell proliferation as compared with that of scrambled decoy ODN.
CONCLUSION: The results demonstrated in this study suggest the potential usefulness of NFkappaB decoy ODN for gene therapy of inflammatory synovitis of RA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908694     DOI: 10.1093/rheumatology/39.7.749

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

1.  Subcellular localization as a limiting factor for utilization of decoy oligonucleotides.

Authors:  Anca Bene; Richard C Kurten; Timothy C Chambers
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

2.  In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  Virchows Arch       Date:  2005-10-05       Impact factor: 4.064

3.  Orthopaedic wear particle-induced bone loss and exogenous macrophage infiltration is mitigated by local infusion of NF-κB decoy oligodeoxynucleotide.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Luis A Córdova; Florence Loi; Emmanuel Gibon; Laura Lu; Karthik Nathan; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-09-13       Impact factor: 4.396

4.  Photochemical control of DNA decoy function enables precise regulation of nuclear factor κB activity.

Authors:  Jeane M Govan; Mark O Lively; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2011-07-29       Impact factor: 15.419

Review 5.  Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?

Authors:  Kyung-Hyun Kim; Kwan-Kyu Park
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

6.  The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.

Authors:  Gert E Hein; Markus Köhler; Peter Oelzner; Günter Stein; Sybille Franke
Journal:  Rheumatol Int       Date:  2004-12-03       Impact factor: 2.631

7.  Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathway.

Authors:  Jung Ok Ban; Dae Hwan Kim; Hee Pom Lee; Chul Ju Hwang; Jung-Hyun Shim; Dae Joong Kim; Tae Myoung Kim; Heon-Sang Jeong; Seong Su Nah; Hanyong Chen; Zigang Dong; Young Wan Ham; Youngsoo Kim; Sang-Bae Han; Jin Tae Hong
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 8.  Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.

Authors:  Leila Farahmand; Behrad Darvishi; Keivan Majidzadeh-A
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Authors:  Inès Souissi; Imen Najjar; Laurent Ah-Koon; Pierre Olivier Schischmanoff; Denis Lesage; Stéphanie Le Coquil; Claudine Roger; Isabelle Dusanter-Fourt; Nadine Varin-Blank; An Cao; Valeri Metelev; Fanny Baran-Marszak; Remi Fagard
Journal:  BMC Cell Biol       Date:  2011-04-12       Impact factor: 4.241

Review 10.  Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.

Authors:  Sander W Tas; Margriet J B M Vervoordeldonk; Paul P Tak
Journal:  Curr Gene Ther       Date:  2009-06       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.